Back to Results
First PageMeta Content
Organic chemistry / Pharmacology / Pharmaceutical sciences / Eli Lilly and Company / Hypnotics / Quetiapine / Antipsychotic / Olanzapine / Food and Drug Administration / Atypical antipsychotics / Piperazines / Chemistry


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may
Add to Reading List

Open Document

File Size: 89,55 KB

Share Result on Facebook

Company

Pfizer Inc. / Policy Food / Eli Lilly and Company / AstraZeneca Pharmaceuticals LP / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

individual product / generic products / /

MedicalCondition

schizophrenia / bipolar mania / bipolar disorder / /

Organization

Jayne E. Peterson /S/ Director Division / National Institute of Health / Psychopharmacologic Drugs Advisory Committee / Tolino _________/S/__________ Director / Ethics and Integrity Staff Office / Management Staff office of Policy / office of Management Michael F. Ortwerth / U.S. Food and Drug Administration / Renal Drugs Advisory Committee / American Heart Association / /S/ Director Division / DEPARTMENT OF HEALTH / Management Center for Drug Evaluation and Research Name of Temporary Voting Member / Advisory Committee / Cardiovascular and Renal Drugs Advisory Committee / /

Person

Randall W. Lutter / Michael F. Ortwerth / Edward Pritchett / Jayne E. Peterson / Vince Tolino / /

Position

Cardiologist / Professor of Cardiology and Pharmacology / Deputy Commissioner for Policy / SGE consultant / Deputy Commissioner / Consultant / /S/ Director / member / /

Product

olanzapine / ziprasidone hydrochloride / Seroquel / Geodon / Zyprexa / S-040 / S-032 / S-045 / /

SocialTag